Prognostic relevance of p53 alterations and Mib-1 proliferation index in subgroups of primary liposarcomas

Clinical Cancer Research

Volumn 5, Issue 10, 1999, Pages 2830-2835

  Schneider Stock, Regine ^a   Ziegeler, Anke ^a   Haeckel, Carsten ^a   Franke, Dagmar S ^a   Rys, Janusz ^b   Roessner, Albert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL PROLIFERATION; DNA POLYMORPHISM; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPOSARCOMA; MALE; MUTATION RATE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SEQUENCE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NUCLEAR; CELL DIVISION; FEMALE; HUMANS; KI-67 ANTIGEN; LIPOSARCOMA; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032696787     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ichikawa, A., Kinoshita, T., Watanabe, T., Kato, H., Nagai, H., Tsushita, K., Saito, H., and Hotta, T. N. Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. N. Engl. J. Med., 337: 529-534, 1997.
2. DeAnta, J. M., Jassem, E., Resell, R., Martinez-Roca, M., Jassem, J., Matinez-Lopez, E., Monzo, M., Sanchez-Hernandez, J. J., and Moreno, I. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis. Oncogene, 15: 2951-2958, 1997.
3. Cordon-Cardo, C., Latres, E., Drobnjak, M., Oliva, M. R., Pollack, D., Woodruff, J. M., Marechal, V., Chen, J., Brennan, M. F., and Levine, A. J. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res., 54: 794-799, 1994.
4. Wurl, P., Meye, A., Berger, D., Bache, M., Lautenschlager, C., Schmidt, H., Kalthoff, H., Rath, F. W., and Taubert, H. Prognostic relevance of C-terminal Mdm2 detection is enhanced by p53 positivity in soft tissue sarcomas. Diagn. Mol. Pathol., 6: 249-254, 1997.
5. Wurl, P., Meye, A., Schmidt, H., Lautenschläger, C., Kalthoff, H., Rath, F. W., and Taubert, H. High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities. Oncogene, 9: 1183-1185, 1998.
6. Taubert, H., Meye, A., and Wurl, P. Prognosis is correlated with p53 mutation type for soft tissue sarcoma patients. Cancer Res., 56: 4134-4136, 1996.
7. Drobnjak, M., Latres, E., Pollack, D., Karpeh, M., Dudas, M., Woodruff, J. M., Brennan, M. F., and Cordon-Cardo, C. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas. J. Natl. Cancer Inst., 86; 549-554, 1994.
8. Kawai, A., Noguchi, M., Beppu, Y., Yokoyama, R., Mukai, K., Hirohashi, S., Inoue, H., and Fukuma, H. Nuclear immunoreaction of p53 protein in soft tissue sarcomas. Cancer (Phila.), 73: 2499-2505, 1994.
9. Nakanishi, H., Ohsawa, M., Naka, N., Uchida, A., Ochi, T., and Aozasa, K. Immunohistochemical detection of bcl-2 and p53 proteins and apoptosis in soft tissue sarcoma: their correlations with prognosis. Oncology, 54: 238-244, 1997.
10. O'Reilley, P. E., Raab, S. S., Niemann, T. H., Rodgers, J. R., and Robinson, R. A. p53 proliferating cell nuclear antigen and Ki-67 expression in extrauterine leiomyosarcomas. Mod. Pathol., 10: 91-97, 1997.
11. DeiTos, A. P., Doglioni, C., Piccinin, S., Maestro, R., Mentzel, T., Barbareschi, M., Boiocchi, M., and Fletcher, C. D. M. Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma. J. Pathol., 181: 8-13, 1997.
12. 1-S checkpoint in myxoid and round cell liposarcoma. Am. J. Pathol., 151: 1531-1539, 1997.
13. Pilotti, S., DellaTorre, G., Lavarino, C., DiPalma, S., Sozzi, G., Minoletti, F., Rao, S., Pasquini, G., Azzarelli, A., Rilke, F., and Pierotti, M. A. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms. J. Pathol., 191: 14-24, 1997.
14. Schneider-Stock, R., Walter, H., Radig, K., Rys, J., Bosse, A., Kuhnen, C., Hoang-Vu, C., and Roessner, A. Mdm2 amplification and loss of heterozygosity at Rb and p53 genes: no simultaneous alterations in the oncogenesis of liposarcomas. J. Cancer Res. Clin. Oncol., 124: 532-540, 1998.
15. Schneider-Stock, R., Walter, H., Rys, J., Radig, K., and Roessner, A. No correlation of c-myc overexpression and p53 mutations in liposarcomas. Virchows Arch. A Pathol. Anat. Histol., 433: 315-321, 1998.
16. Schneider-Stock, R., Epplen, J. T., Walter, H., Radig, K., Rys, J., Epplen, C., Hoang-Vu, C., Niezabitowski, A., and Roessner, A. Telomeric lengths and telomerase activity in liposarcomas. Mol. Carcinog., 24: 144-151, 1999.
17. Crozat, A., Aman, P., Mandahl, N., and Ron, D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature (Lond.), 363: 640-644, 1993.
18. Enzinger, F. M., and Weiss, S. W. Soft Tissue Tumors, Ed. 3, pp. 431-466. Baltimore, MD: Mosby, 1995.
19. Ayan, I., Dogan, O., Kebudi, R., Bavbek, B., Alatli, C., Dervisoglu, S., Disci, R., and Demiryont, M. Immunhistochemical detection of p53 protein in rhabdomyosarcoma: association with clinicopathological features and outcome. J. Pediatr. Hematol. Oncol., 19: 48-53, 1997.
20. Nawa, G., Ueda, T., Mori, S., Yoshikawa, H., Fukuda, H., Ishiguro, S., and Funai, H. Prognostic significance of Ki67 (MIB1) proliferation index and p53 over-expression in chondrosarcomas. Int. J. Cancer, 69: 86-91, 1996.
21. Feugeas, O., Gueriec, N., Babin-Boilletot, M. L., Simon, P., Babin, S., Thyss, A., Hofman, P., Terrier, P., Kalifa, C., Brunat-Mentiny, M., Patricot, L. M., and Oberling, F. Loss of heterozygosity of the Rb gene is a poor prognostic factor in patients with osteosarcoma. J. Clin. Oncol., 14: 467-472, 1996.
22. Fletcher, C. D., Akerman, M., DalCin, P., deWever, I., Mandahl, N., Mertens, F., Mitelman, F., Rosai, J., Rydholm, A., Sciot, R., Tallini, G., vandeVen, W., and Willen, H. Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am. J. Pathol., 48: 623-630, 1996.
23. Niezabitowski, A., Rys, J., Roessner, A., Lackowska, B., Schneider-Stock, R., Gruchala, A., Wasilewska, A., Kruszak, A., Swiatkiewicz, I., Sokolowski, A., Szklarski, W., Jaszcz, A., and Stelmach, A. Assessment of proliferation activity, DNA values and some clinicopathologic parameters in mesenchymal tumors. Immunhistochemical and flow cytometric study. Gen. Diagn. Pathol., 142: 327-333, 1997.
24. Mentzel, T., and Fletcher, C. D. M. Lipomatous tumours of soft tissues: an update. Virchows Arch. A Pathol. Anat. Histol., 427: 353-363, 1995.
25. Trojani, M., Contesso, G., Coindre, J. M., Rouesse, J., Bui, N. B., deMascarle, A., Goussot, J. F., David, M., Bonichon, F., and Lagarde, C. Soft tissue sarcomas of adults: study of pathological prognostic variables and definition of a histopathological grading system. Int. J. Cancer, 33: 37-42, 1984.
26. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
27. Schneider-Stock, R., Radig, K., Oda, Y., Mellin, W., Rys, A., Niezabitowski, A., and Roessner, A. p53 gene mutations in soft-tissue sarcomas-correlations with p53 immunohistochemistry and DNA ploidy. J. Cancer Res. Clin. Oncol., 123: 211-218, 1997.
28. Budowle, B., Chakraborty, R., Giusti, A. M., Eisenberg, A. J., and Allen, R. C. Analysis of the variable number of tandem repeats locus D1S80 by the polymerase chain reaction followed by high resolution polyacrylamide gel electrophoresis. Am. J. Hum. Genet., 48: 137-144, 1991.
29. Goldmann, D., and Merril, C. R. Silver staining of DNA in polyacrylamide gels: linearity and effect of fragment size. Electrophoresis, 3: 24-26, 1982.
30. Casey, G., Lopez, M. E., Ramos, J. C., Plummer, S. J., Arboleda, M. J., Shaughnessy, M., Karlan, B., and Slamon, D. J. DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene, 13: 1971-1981, 1996.
31. Kubbutat, M. H., Jones, S. N., and Vousden, K. H. Regulation of p53 stability by Mdm2. Nature (Lond.), 387: 299-303, 1997.
32. Lane, D, P., and Crawford, L. T antigen is bound to a host protein in SV 40-transformed cells. Nature (Lond.), 278: 261-263, 1979.
33. Mousses, S., McAuley, L., Bell, R. S., Kandel, R., and Andrulis, I. L. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas. Mod. Pathol., 9: 1-6, 1996
34. Sprogoe-Jakobsen, S., and Holund, B. Immunohistochemistry (Ki-67 and p53) as a tool in determining malignancy in smooth muscle neoplasms (exemplified by a myxoid leiomyosarcoma of the uterus). Acta Pathol. Microbiol. Immunol. Scand., 104: 705-708, 1996.
35. Yang, P., Hirose, T., Hasegawa, T., Seki, K., Sano, T., and Hizawa, K. Prognostic implication of the p53 protein and Ki-67 antigen immunohistochemistry in malignant fibrous histiocytoma. Cancer (Phila.), 76: 618-625, 1995.
36. Heslin, M. J., Cordon-Cardo, C., Lewis, J. J., Woodruff, J. M., and Brennan, M. Ki-67 detected by MIB-1 predicts distant metastasis and tumor mortality in primary, high grade extremity soft tissue sarcoma. Cancer (Phila.), 83: 490-497, 1998.
37. Schneider-Stock, R., Haeckel, C., Radig, K., Pein, C. D., and Roessner, A. Improved detection of p53 mutations in soft-tissue tumors using a new gel composition for automated nonradioactive analysis of single-strand conformation polymorphism. Electrophoresis, 18: 2849-2851, 1997.